Erin Hoffmann, Managing Director at Additional Ventures, Palo Alto, California, United States — verified investor profile. See contact routes.
Additional Ventures' mission is to cure single ventricle heart disease through transformative research and strategic investments that revolutionize treatment and care. They spur catalytic collaboration within the single ventricle community, facilitate faster and better science through agile approaches to research funding, and ensure researchers have the resources needed to drive toward a cure. Since 2020, they have been embedded within the biomedical research community, optimizing and accelerating high-quality single ventricle research, having provided over $95M in single ventricle research funding.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Palo Alto.
Investors like Erin Hoffmann · Full investor directory · Investor access · Company funding database